Pembrolizumab found Clinically Beneficial in Advanced Clear Cell Gynecological Cancer: JAMA Dr Pooja N.31 March 2025 9:15 PM ISTAdvanced clear cell gynecological cancers (CCGCs), including clear cell ovarian cancer (CCOC), clear cell endometrial cancer (CCEC), and others, are...
Immunotherapy drug combination helps extend survival in patients with metastatic melanoma Dr. Kamal Kant Kohli22 Aug 2023 9:45 AM ISTUSA: An immunotherapy drug combination was shown to be an effective second-line therapy for metastatic melanoma, an aggressive and deadly type of...
PD-1 inhibitors Highly Effective for Colorectal Cancer in Lynch Syndrome Patients Aditi3 Aug 2023 8:00 PM ISTResearch article published in the European Journal of Cancer has concluded that Programmed death-1 inhibitors are highly effective for colorectal...
Peresolimab beneficial for patients with rheumatoid arthritis, compared with placebo: NEJM Jacinthlyn Sylvia20 July 2023 11:30 AM ISTIn a recent study, Jay Tuttle and team have reported encouraging results from a phase 2a clinical trial of Peresolimab, a humanized IgG1 monoclonal...
Rare case of Pembrolizumab induced-C3 glomerulonephritis and RBC cast nephropathy- A report Dr. Shravani Dali1 Jun 2023 8:00 PM ISTImmune checkpoint inhibitors (ICIs) are increasingly being used in the treatment of several cancers. Pembrolizumab is an anti-programmed cell death-1...
